Good morning :)
Switch to
Place Order

Thyrocare Technologies Ltd

THYROCARE
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹7,140 cr, stock is ranked 391
Moderate RiskStock is 2.98x as volatile as Nifty
1,351.901.45 (+0.11%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹7,140 cr, stock is ranked 391
Moderate RiskStock is 2.98x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
63.11
PB RatioPB Ratio
16.71
Dividend YieldDiv. Yield
1.85%
Sector PESector PE
40.44
Sector PBSector PB
5.67
Sector Div YldSctr Div Yld
0.61%

Forecast & RatingsDetailed Forecast 

60%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Thyrocare Technologies Limited is a diagnostic chain company which offers a range of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.

Investor PresentationView older 

May 10, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021379.32413.52441.44507.0593.2885.1488.40113.15
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Disclosure under SEBI Takeover Regulations 
Announced OnAug 5, 2021

Thyrocare Technologies Limited has forwarded a copy of recommendation of the Independent Directors Committee on the Open Offer being made by the Acquirers, under Regulation 26(7) of SEBI (SAST) Regulations, which has also been published in the same newspapers in which the public announcement of the Open Offer was published. | Download

Thyrocare Technologies Limited has forwarded a copy of recommendation of the Independent Directors Committee on the Open Offer being made by the Acquirers, under Regulation 26(7) of SEBI (SAST) Regulations, which has also been published in the same newspapers in which the public announcement of the Open Offer was published. | Download

Updates 
Announced OnAug 2, 2021

ᅡᅠJM Financial Limitedᅡᅠᅡᅠhas submitted to the Exchange a copy of Letter of Offer. | Download

ᅡᅠJM Financial Limitedᅡᅠᅡᅠhas submitted to the Exchange a copy of Letter of Offer. | Download

Cash Dividend 
Ex. DateJun 17, 2021

Final • Div/Share: ₹ 15

See all events